Evidence map›Paper›PMID 32275976›Full record

ArticleThe Journal of investigative dermatology2020

PD-1, PD-L1, and BIM as Predictors of Sentinel Lymph Node Metastasis in Primary Cutaneous Melanoma.

Felix F Kung, Suzette M Arias-Mejias, Enrica Quattrocchi, Sindhuja Sominidi-Damodaran, Alina G Bridges, Julia S Lehman, Amy L Weaver, Alexander Meves

Open access · greenAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of investigative dermatology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 96% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Felix F KungMayo Clinic Alix School of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Suzette M Arias-MejiasDepartment of Dermatology, Mayo Clinic, Rochester, Minnesota, USA.
Enrica QuattrocchiDepartment of Dermatology, Mayo Clinic, Rochester, Minnesota, USA.
Sindhuja Sominidi-DamodaranDepartment of Dermatology, Mayo Clinic, Rochester, Minnesota, USA.
Alina G BridgesDivision of Dermatopathology and Cutaneous Immunopathology, Mayo Clinic, Rochester, Minnesota, USA.
Julia S LehmanDivision of Dermatopathology and Cutaneous Immunopathology, Mayo Clinic, Rochester, Minnesota, USA.
Amy L WeaverDivision of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota, USA.
Alexander MevesDepartment of Dermatology, Mayo Clinic, Rochester, Minnesota, USA. Electronic address: meves.alexander@mayo.edu.
Mayo Clinic · US

Funding

Mayo Clinic Center for Translational Science ActivitiesUL1TR000135 · NCATS · MAYO CLINIC ROCHESTER · PI KHOSLA, SUNDEEP · 2012 to 2015
$41.2M
Precision Medicine by Targeting Cell Adhesion in MelanomaK08CA215105 · NCI · MAYO CLINIC ROCHESTER · PI MEVES, ALEXANDER · 2017 to 2021
$854k
NCATS NIH HHS UL1 TR000135NCI NIH HHS K08 CA215105
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdultAgedB7-H1 AntigenBcl-2-Like Protein 11FemaleHumansIntegrin beta3Lymphatic MetastasisMaleMelanomaMiddle AgedProgrammed Cell Death 1 ReceptorSentinel Lymph NodeSkin NeoplasmsYoung AdultB7-H1 AntigenBcl-2-Like Protein 11CD274 protein, humanIntegrin beta3PDCD1 protein, humanProgrammed Cell Death 1 Receptor

Identifiers

PMID32275976
PMCPMC7541661
OpenAlexW3015992716

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.